ODT’s Most-Read Stories This Week—March 26

Grabbing ODT readers’ attention above all this week was an exclusive distribution deal in which Zimmer Biomet will distribute Biocompsites’ genex bone graft substitute in the U.S.

The American Academy of Orthopaedic Surgeons’ annual meeting took place during the week, and two announcements from the conference caught readers’ eyes: Stryker unveiled its new Insignia hip stem for total hip and hemiarthoplasty, and Pixee Medical announced the imending launch of its Knee+ augmented reality guidance system for knee replacement.

In M&A news, DePuy Synthes acquired Cuptimize hip-spine analysis to help surgeons better understand, measure, and address pelvic tilt prior to hip replacement.

In case you missed it, here are ODT’s most popular stories of the week:

1. Zimmer Biomet, Biocomposites Begin Exclusive Distribution Deal

2. AAOS22: Stryker Reveals Insignia Hip Stem

3. AAOS22: Pixee Medical to Launch Knee+ in the U.S.

4. DePuy Synthes Buys Cuptimize Hip-Spine Analysis

5. Medin Technologies and AMT Medical to Create Velocity Medtech